D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$452M |
| 2 |
Apple
AAPL
|
$291M |
| 3 |
Schlumberger
SLB
|
$264M |
| 4 |
Johnson & Johnson
JNJ
|
$254M |
| 5 |
TJX Companies
TJX
|
$221M |
Top Sells
| 1 |
Walt Disney
DIS
|
$313M |
| 2 |
Amazon
AMZN
|
$307M |
| 3 |
YHOO
Yahoo Inc
YHOO
|
$285M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$205M |
| 5 |
Bristol-Myers Squibb
BMY
|
$194M |
Sector Composition
| 1 | Technology | 16.98% |
| 2 | Healthcare | 12.86% |
| 3 | Financials | 11.44% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Navient
NAVI
$1.37B
| $50.6M | 0.09% |
3,426,077
-801,717
| -19% | -$11.8M |
|
227
American Airlines Group
AAL
$8.63B
| $50.5M | 0.09% |
1,194,113
+449,506
| +60% | +$19M |
|
228
Ashland
ASH
$2.51B
| $50.5M | 0.09% |
833,615
+505,371
| +154% | +$30.6M |
|
229
Charles River Laboratories
CRL
$8.07B
| $50.4M | 0.09% |
560,791
-106,507
| -16% | -$9.58M |
|
230
Viatris
VTRS
$12.2B
| $50.4M | 0.09% |
1,293,237
+248,320
| +24% | +$9.68M |
|
231
W.W. Grainger
GWW
$47.5B
| $50M | 0.09% |
214,686
+115,576
| +117% | +$26.9M |
|
232
Allegion
ALLE
$14.8B
| $49.7M | 0.09% |
656,229
+84,747
| +15% | +$6.42M |
|
233
PG&E
PCG
$33.2B
| $49.4M | 0.09% |
744,065
-463,907
| -38% | -$30.8M |
|
234
Teva Pharmaceuticals
TEVA
$21.7B
| $49.2M | 0.09% |
1,533,635
-858,414
| -36% | -$27.5M |
|
235
Vanguard FTSE Emerging Markets ETF
VWO
$97.2B
| $49M | 0.09% |
1,232,831
+140,031
| +13% | +$5.56M |
|
236
NVIDIA
NVDA
$4.07T
| $48.8M | 0.09% |
17,936,520
+1,465,000
| +9% | +$3.99M |
|
237
Lowe's Companies
LOW
$151B
| $48.7M | 0.09% |
592,842
-819,605
| -58% | -$67.4M |
|
238
XPO
XPO
$15.4B
| $48.3M | 0.08% |
2,914,580
+696,158
| +31% | +$11.5M |
|
239
H&R Block
HRB
$6.85B
| $47.6M | 0.08% |
2,048,350
+1,911,955
| +1,402% | +$44.5M |
|
240
Keurig Dr Pepper
KDP
$38.9B
| $46.9M | 0.08% |
479,349
-215,752
| -31% | -$21.1M |
|
|
241
Bristol-Myers Squibb
BMY
$96B
| $46.4M | 0.08% |
853,810
-3,573,354
| -81% | -$194M |
|
242
Snap
SNAP
$12.4B
| $45.9M | 0.08% |
+2,037,359
| New | +$45.9M |
|
243
Armstrong World Industries
AWI
$8.58B
| $45.8M | 0.08% |
995,573
+97,085
| +11% | +$4.47M |
|
244
MRC Global
MRC
$1.28B
| $45.7M | 0.08% |
2,491,082
-128,125
| -5% | -$2.35M |
|
245
Aflac
AFL
$57.2B
| $45.4M | 0.08% |
1,252,676
-36,464
| -3% | -$1.32M |
|
|
CIT
246
DELISTED
CIT Group Inc.
CIT
| $45.1M | 0.08% |
1,049,722
+242,303
| +30% | +$10.4M |
|
247
Chubb
CB
$111B
| $44.8M | 0.08% |
328,462
+20,943
| +7% | +$2.85M |
|
248
Carlisle Companies
CSL
$16.9B
| $44.5M | 0.08% |
417,920
+28,930
| +7% | +$3.08M |
|
|
DCUC
249
DELISTED
Dominion Energy, Inc.
DCUC
| $44.2M | 0.08% |
+878,000
| New | +$44.2M |
|
250
Itaú Unibanco
ITUB
$76.6B
| $44.2M | 0.08% |
7,322,813
+841,021
| +13% | +$5.07M |
|